Showing results (31-40 of 119) with videos related to

Sort By:
Pageof 12
Cancers|February 25, 2023
Identification of T Cell Receptors Targeting a Neoantigen Derived from Recurrently Mutated FGFR3Tomohiro Tate, Saki Matsumoto, Kensaku Nemoto, et al.
Drug Metabolism and Pharmacokinetics|December 25, 2004
Eighteen novel polymorphisms of the CYP2A13 gene in JapaneseMasaki Fujieda, Hiroshi Yamazaki, Kazuma Kiyotani, et al.
Oncoimmunology|March 28, 2017
Integrated analysis of somatic mutations and immune microenvironment in malignant pleural mesotheliomaKazuma Kiyotani, Jae-Hyun Park, Hiroyuki Inoue, et al.
Oncoimmunology|June 14, 2025
Mutant p53-specific CD8TCR-therapy combined with a CD4TCR prevents relapse of cancer and outgrowth of micrometastasesVasiliki Anastasopoulou, Hans Schreiber, Ching-En Lee, et al.
Molecular Pharmacology|January 27, 2004
Identification of a novel polymorphic enhancer of the human CYP3A4 geneKeiko Matsumura, Tetsuya Saito, Yoshiki Takahashi, et al.
Drug Metabolism and Pharmacokinetics|October 23, 2004
CYP3A5 Contributes significantly to CYP3A-mediated drug oxidations in liver microsomes from Japanese subjectsSatoshi Yamaori, Hiroshi Yamazaki, Shunsuke Iwano, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 28, 2005
Cyp2a6 is a principal enzyme involved in hydroxylation of 1,7-dimethylxanthine, a main caffeine metabolite, in humansMiyuki Kimura, Hiroshi Yamazaki, Masaki Fujieda, et al.
Drug Metabolism and Pharmacokinetics|December 25, 2004
Two novel haplotypes of CYP2D6 gene in a Japanese populationHiroshi Yamazaki, Kazuma Kiyotani, Satoshi Tsubuko, et al.
Cancer Science|February 26, 2008
Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapyKazuma Kiyotani, Taisei Mushiroda, Mitsunori Sasa, et al.
Pageof 12